PROVIDER PROFILE · NPI 1871675785

John Pantazopoulos

Internal MedicineFair Lawn, NJI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

211

Beneficiaries

—

Total drug cost

$19K

Distinct drugs

Brand share

34.6%

Top prescribed drugs

Nifedipine55 claims

Rosuvastatin Calcium47 claims

Metoprolol Succinate33 claims

Levothyroxine Sodium19 claims

Apixaban18 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$129

Payment records

By payment type

Food and Beverage$129

REFERRAL NETWORK

Where John Pantazopoulos's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 109 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
THE VALLEY HOSPITAL INC.	1,194	2,699
Marcus Williams Cardiology · Fair Lawn, NJ	327	492
Howard Seigerman Diagnostic Radiology · Waldwick, NJ	214	279
Kyung-Hwa Rhee Diagnostic Radiology · Waldwick, NJ	150	193
Glenn Krinsky Diagnostic Radiology · Waldwick, NJ	144	199
Lauren Levy Diagnostic Radiology · Waldwick, NJ	123	171
Jaclyn Calem-Grunat Diagnostic Radiology · Waldwick, NJ	115	143
RAMBLER, LOUIS	114	163
Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ	113	182
RAMAN, JENNIFER	86	156
NPI 1316946478	84	132
Thomas Molloy Cardiology · Fair Lawn, NJ	75	126

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history